BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Imidazoline Receptors

Below is an extended Imidazoline Receptors research listing. Click here to return to the Imidazoline Receptors main in depth entry.

Recent Publications on Imidazoline Receptors:

[Imidazoline receptors.] 20th August, 2008
Tbilisi State Medical University, Department of Pharmacology.
The antiarrhythmic effect of centrally administered rilmenidine involves muscarinic receptors, protein kinase C and mitochondrial signalling pathways.
BACKGROUND AND PURPOSE: We have previously demonstrated that stimulation...
Direct Link
13th August, 2008
Department of Anesthesiology, Osaka University Medical School, Osaka,
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway.
Autophagy is a major clearance route for intracellular aggregate-prone...
Direct Link
7th August, 2008
Department of Medical Genetics, University of Cambridge, Cambridge
Imidazoline I(1) receptor-mediated reduction of muscle rigidity in the reserpine-treated murine model of Parkinson's disease.
To explore the therapeutic potential of imidazoline I(1) receptor ligands...
Direct Link
8th July, 2008
Laboratory of CNS Pharmacology, Graduate School of Pharmaceutical
G-protein inwardly rectifying potassium channels are involved in the hypotensive effect of I1-imidazoline receptor selective ligands.
OBJECTIVE: The present study examined the role of G-protein inwardly...
Direct Link
4th July, 2008
Laboratoire de Neurobiologie et Pharmacologie Cardiovasculaire, INSERM
Effects of spinal alpha(2)-adrenoceptor and I(1)-imidazoline receptor activation on hindlimb movement induction in spinal cord-injured mice.
A partial recovery of locomotor functions has been shown in spinal...
Direct Link
17th June, 2008
Neuroscience Unit, RC-9800, Laval University Medical Center, 2705 Laurier
Nischarin inhibits LIM kinase to regulate cofilin phosphorylation and cell invasion.
Nischarin is a novel protein that regulates cell migration by inhibiting...
Direct Link
17th June, 2008
Department of Biochemistry and Molecular Biology, School of Medicine, LSU
Imidazole receptors. 10th May, 2008
Baker Medical Research Institute, Neuropharmacology Laboratory, Commercial
Focus on hypertension and overall cardiovascular risk: a report from the 21st scientific meeting of the International Society of Hypertension. 19th April, 2008
Medical Information Department, Prous Science.
A novel synthesis of chiral guanidinium receptors and their use in unfolding the energetics of enantiorecognition of chiral carboxylates.
A novel synthetic route to the versatile chiral bicyclic guanidinium...
Direct Link
4th April, 2008
Department of Chemistry, Technical University of Munich,
Dexmedetomidine increases hippocampal phosphorylated extracellular signal-regulated protein kinase 1 and 2 content by an alpha 2-adrenoceptor-independent mechanism: evidence for the involvement of imidazoline I1 receptors.
BACKGROUND: Dexmedetomidine is a potent and selective alpha2-adrenoceptor...
Direct Link
13th March, 2008
Department of Anesthesiology, Beaujon University Hospital, Clichy, France.
Synthesis, molecular structure and reactivity of 5-methylidene-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolines. 4th March, 2008
Department of Chemical Technology of Drugs, Medical University of Gdansk,
Dexmedetomidine reduces long-term potentiation in mouse hippocampus.
BACKGROUND: Dexmedetomidine (Precedex; Abbott Laboratories, Abbott Park,...
Direct Link
24th January, 2008
Department of Anesthesiology, National Defense Medical College,
Brainstem phosphorylated extracellular signal-regulated kinase 1/2-nitric-oxide synthase signaling mediates the adenosine A2A-dependent hypotensive action of clonidine in conscious aortic barodenervated rats.
The cellular mechanisms that underlie the enhancement of clonidine-evoked...
Direct Link
19th January, 2008
Department of Pharmacology and Toxicology, School of Medicine, East
Agmatine : metabolic pathway and spectrum of activity in brain. 20th December, 2007
Department of Psychiatry and Behavioral Neurosciences, Loyola University
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional